2025年,中国创新药出海的步伐持续加速,整个行业呈现出一派蓬勃发展的态势。数据显示,今年上半年,创新药对外授权的总金额已逼近660亿美元,近乎达到2024年全年的交易总额,其中有多笔交易的金额超过了10亿美元。在跨国药企首付款超过5000万美元的BD交易中,超过40%来自中国生物科技企业。而在四年前,这一比例还不到5%,充分展现了中国创新药在全球医药市场中的地位实现了历史性跨越。1中国创新药出海...
Source Link2025年,中国创新药出海的步伐持续加速,整个行业呈现出一派蓬勃发展的态势。数据显示,今年上半年,创新药对外授权的总金额已逼近660亿美元,近乎达到2024年全年的交易总额,其中有多笔交易的金额超过了10亿美元。在跨国药企首付款超过5000万美元的BD交易中,超过40%来自中国生物科技企业。而在四年前,这一比例还不到5%,充分展现了中国创新药在全球医药市场中的地位实现了历史性跨越。1中国创新药出海...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.